🇺🇸 FDA
Pipeline program

ART-I02

ART-I02-001-NL

Phase 1 gene_therapy active

Quick answer

ART-I02 for Arthritis, Rheumatoid is a Phase 1 program (gene_therapy) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Arthritis, Rheumatoid
Phase
Phase 1
Modality
gene_therapy
Status
active

Clinical trials